Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-21 2:00 pm Purchase | 2024-02-20 | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,043,744 9.300% | 307,525 (+8.23%) | Filing History |
| 2024-02-14 10:28 am Purchase | 2024-02-13 | 13D | XPERI INC XPER | Rubric Capital Management LP | 3,736,219 8.600% | 435,000 (+13.18%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Rubric Capital Management LP | 6,644,530 7.040% | 6,644,530 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | GOODRX HLDGS INC GDRX | Rubric Capital Management LP | 5,872,806 6.360% | 5,872,806 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | GOLAR LNG LTD GLNG | Rubric Capital Management LP | 6,506,757 6.210% | 154,001 (+2.42%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Rubric Capital Management LP | 2,907,501 8.210% | 2,907,501 (New Position) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | OVID THERAPEUTICS INC OVID | Rubric Capital Management LP | 5,315,969 7.520% | -1,512,096 (-22.15%) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | PAR PACIFIC HOLDINGS INC PARR | Rubric Capital Management LP | 1,199,749 1.980% | -1,849,251 (-60.65%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | SCPHARMACEUTICALS INC SCPH | Rubric Capital Management LP | 3,500,000 9.760% | 3,500,000 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Rubric Capital Management LP | 334,481 5.490% | 13,294 (+4.14%) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | DIGIMARC CORP DMRC | Rubric Capital Management LP | 0 0.000% | -1,214,593 (Position Closed) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | MATIV HOLDINGS, INC. MATV | Rubric Capital Management LP | 4,000,000 7.380% | 980,000 (+32.45%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | ANI PHARMACEUTICALS INC ANIP | Rubric Capital Management LP | 1,125,000 5.510% | 1,125,000 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | BGC GROUP INC BGC | Rubric Capital Management LP | 20,000,000 5.170% | 1,750,000 (+9.59%) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | CHIMERIX INC CMRX | Rubric Capital Management LP | 0 0.000% | -4,779,020 (Position Closed) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Rubric Capital Management LP | 2,758,253 8.460% | -575,375 (-17.26%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | WEREWOLF THERAPEUTICS INC HOWL | Rubric Capital Management LP | 1,935,357 5.350% | 99,970 (+5.45%) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | KOPPERS HOLDINGS, INC. KOP | Rubric Capital Management LP | 1,007,341 4.840% | -126,499 (-11.16%) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Rubric Capital Management LP | 0 0.000% | -552,975 (Position Closed) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | HAPPEN, INC. HAPN | Rubric Capital Management LP | 0 0.000% | -5,826,128 (Position Closed) | Filing History |